Yu Hou

2.6k total citations
78 papers, 1.8k citations indexed

About

Yu Hou is a scholar working on Hematology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Yu Hou has authored 78 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Hematology, 20 papers in Immunology and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Yu Hou's work include Platelet Disorders and Treatments (55 papers), Blood groups and transfusion (22 papers) and Autoimmune Bullous Skin Diseases (15 papers). Yu Hou is often cited by papers focused on Platelet Disorders and Treatments (55 papers), Blood groups and transfusion (22 papers) and Autoimmune Bullous Skin Diseases (15 papers). Yu Hou collaborates with scholars based in China, United States and Canada. Yu Hou's co-authors include Ming Hou, Jun Peng, Xinguang Liu, Linlin Shao, Hai Zhou, Miao Xu, Jihua Qiu, Panpan Han, Guosheng Li and Heyu Ni and has published in prestigious journals such as Nucleic Acids Research, Blood and PLoS ONE.

In The Last Decade

Yu Hou

77 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Hou China 22 918 586 333 313 275 78 1.8k
Toshiaki Yujiri Japan 21 573 0.6× 954 1.6× 381 1.1× 297 0.9× 159 0.6× 72 2.2k
Nunzia Montuori Italy 27 422 0.5× 916 1.6× 392 1.2× 110 0.4× 191 0.7× 82 2.0k
Michael J. Rauh Canada 22 755 0.8× 1.2k 2.0× 951 2.9× 100 0.3× 491 1.8× 73 2.7k
Emmanuel Karouzakis Switzerland 20 223 0.2× 1.0k 1.8× 481 1.4× 125 0.4× 109 0.4× 30 1.9k
Yasuhiro Horii Japan 8 591 0.6× 558 1.0× 560 1.7× 163 0.5× 136 0.5× 14 1.6k
Albertus T.J. Wierenga Netherlands 22 431 0.5× 659 1.1× 283 0.8× 76 0.2× 155 0.6× 34 1.3k
Akira Kitanaka Japan 23 348 0.4× 751 1.3× 392 1.2× 100 0.3× 240 0.9× 80 1.7k
Chang Kyu Oh United States 15 205 0.2× 392 0.7× 870 2.6× 80 0.3× 170 0.6× 25 1.5k
Kimberly J. Payne United States 29 666 0.7× 819 1.4× 866 2.6× 79 0.3× 231 0.8× 69 2.4k
José Perdomo Australia 16 369 0.4× 711 1.2× 365 1.1× 55 0.2× 70 0.3× 39 1.4k

Countries citing papers authored by Yu Hou

Since Specialization
Citations

This map shows the geographic impact of Yu Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Hou more than expected).

Fields of papers citing papers by Yu Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Hou. The network helps show where Yu Hou may publish in the future.

Co-authorship network of co-authors of Yu Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Hou. A scholar is included among the top collaborators of Yu Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Hou. Yu Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuhan, Yujing Li, Yanan Zhou, et al.. (2025). Nynrin enhances cardiac function by inhibiting mitochondrial permeability transition pore opening upon myocardial ischemia/reperfusion injury. Journal of Molecular and Cellular Cardiology. 209. 93–103. 1 indexed citations
2.
Sun, Lu, Juan Wang, Chenglu Yuan, et al.. (2024). Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial. Blood. 144(17). 1791–1799. 2 indexed citations
3.
Liu, Lu, Yu Hou, Shuqian Xu, et al.. (2023). The mTORC1 pathway participate in hyper-function of B cells in immune thrombocytopenia. Annals of Hematology. 102(9). 2317–2327. 4 indexed citations
4.
Liu, Xinguang, Yu Hou, & Ming Hou. (2023). How we treat primary immune thrombocytopenia in adults. Journal of Hematology & Oncology. 16(1). 4–4. 46 indexed citations
5.
Xin, Min, Lingjun Wang, Lin Li, et al.. (2022). Inhibition of LDHA to induce eEF2 release enhances thrombocytopoiesis. Blood. 139(19). 2958–2971. 15 indexed citations
6.
Ni, Xiaofei, Lingjun Wang, Haoyi Wang, et al.. (2022). Low-dose decitabine modulates myeloid-derived suppressor cell fitness via LKB1 in immune thrombocytopenia. Blood. 140(26). 2818–2834. 12 indexed citations
7.
Wang, Yun, Lei Sheng, Fengjiao Han, et al.. (2022). Efficacy and safety of treatments in newly diagnosed adult primary immune thrombocytopenia: a systematic review and network meta-analysis. EClinicalMedicine. 56. 101777–101777. 12 indexed citations
8.
Hou, Yu, Jie Xie, Shuwen Wang, et al.. (2022). Glucocorticoid receptor modulates myeloid-derived suppressor cell function via mitochondrial metabolism in immune thrombocytopenia. Cellular and Molecular Immunology. 19(7). 764–776. 21 indexed citations
9.
Han, Panpan, Yu Hou, Yajing Zhao, et al.. (2021). Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia. Blood. 138(8). 674–688. 47 indexed citations
10.
Yu, Yafei, Yu Hou, Yajing Zhao, et al.. (2021). Platelet autoantibody specificity and response to rhTPO treatment in patients with primary immune thrombocytopenia. British Journal of Haematology. 194(1). 191–194. 10 indexed citations
11.
Yu, Tianshu, Lingjun Wang, Xiaofei Ni, et al.. (2021). Orelabrutinib, a Selective Bruton's Tyrosine Kinase (BTK) Inhibitor in the Treatment of Primary Immune Thrombocytopenia (ITP). Blood. 138(Supplement 1). 3172–3172. 8 indexed citations
12.
Hou, Yu, Panpan Han, Yajing Zhao, et al.. (2021). Proteomic analysis and microRNA expression profiling of plasma‐derived exosomes in primary immune thrombocytopenia. British Journal of Haematology. 194(6). 1045–1052. 14 indexed citations
13.
Wang, Hailong, Zhen Li, Yu Hou, et al.. (2016). RecET direct cloning and Redαβ recombineering of biosynthetic gene clusters, large operons or single genes for heterologous expression. Nature Protocols. 11(7). 1175–1190. 139 indexed citations
14.
Min, Yanan, Chi‐Yuen Wang, Xiaoxi Li, et al.. (2016). Participation of B‐cell‐activating factor receptors in the pathogenesis of immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 14(3). 559–571. 15 indexed citations
15.
Hu, Yu, Xiuwen Wang, Shuang Yu, et al.. (2015). Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia. Expert Opinion on Therapeutic Targets. 19(6). 723–732. 15 indexed citations
16.
Jernås, Margareta, Yu Hou, Linlin Shao, et al.. (2015). Altered cytokine levels in pediatric ITP. Platelets. 26(6). 589–592. 9 indexed citations
17.
Peng, Jun, Shenglin Ma, Yu Hou, et al.. (2014). Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study. Journal of Thrombosis and Haemostasis. 12(4). 497–504. 91 indexed citations
18.
Xu, Miao, Yu Hou, Lei Sheng, & Jun Peng. (2013). Therapeutic effects of thalidomide in hematologic disorders: a review. Frontiers of Medicine. 7(3). 290–300. 12 indexed citations
19.
Shao, Linlin, Lei Zhang, Yu Hou, et al.. (2012). Th22 Cells as Well as Th17 Cells Expand Differentially in Patients with Early-Stage and Late-Stage Myelodysplastic Syndrome. PLoS ONE. 7(12). e51339–e51339. 37 indexed citations
20.
Liu, Jun, et al.. (2010). The value of transtelephonic electrocardiogram monitoring system during the “Blanking Period” after ablation of atrial fibrillation. Journal of Electrocardiology. 43(6). 667–672. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiaki Yujiri Breakdown of academic impact, for papers by Nunzia Montuori Breakdown of academic impact, for papers by Michael J. Rauh Breakdown of academic impact, for papers by Emmanuel Karouzakis Breakdown of academic impact, for papers by Yasuhiro Horii Breakdown of academic impact, for papers by Albertus T.J. Wierenga Breakdown of academic impact, for papers by Akira Kitanaka Breakdown of academic impact, for papers by Chang Kyu Oh Breakdown of academic impact, for papers by Kimberly J. Payne Breakdown of academic impact, for papers by José Perdomo
Rankless by CCL
2026